Novel Agents for Acute Myeloid Leukemia

Novel Agents for Acute Myeloid Leukemia

Acute myeloid leukemia (AML) is a complex hematological disease characterized by genetic and clinical heterogeneity. Recent advances in the understanding of AML pathogenesis have paved the way for the development of new agents targeting specific molecules or mechanisms that contribute to finally mov...

Full description

Bibliographic Details
Main Authors: Mario Luppi, Francesco Fabbiano, Giuseppe Visani, Giovanni Martinelli, Adriano Venditti
Format: Article
Language:English
Published: MDPI AG 2018-11-01
Series:Cancers
Subjects:
acute myeloid leukemia
“7 + 3” regimen
gemtuzumab ozogamicin
CPX-351
FLT3
midostaurin
enasidenib
palliative care
Online Access:https://www.mdpi.com/2072-6694/10/11/429

Internet

https://www.mdpi.com/2072-6694/10/11/429

Similar Items